NCT06867042View on ClinicalTrials.gov

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Ulcerative Colitis (UC)Ulcerative Colitis, Active Moderate
Interventions
DRUG

Tacrolimus Lipid Suspension for enema

Tacrolimus Lipid Suspension for enema 4 mg/vial

DRUG

Identical Tacrolimus-free Lipid Suspension for Enema

Identical Tacrolimus-free Lipid Suspension for Enema

Sponsors
All Listed Sponsors
collaborator

Novum Pharmaceutical Research Services

INDUSTRY

lead

Jina Pharmaceuticals Inc.

INDUSTRY